Skip to main content
Guselkumab improves effector cytokine levels in PsA patients with inadequate response to TNFi
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Guselkumab improves effector cytokine levels in PsA patients with inadequate response to TNFi
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
1
Monoclonal Antibody
0
1
Anti-Tumor Necrosis Factor (Anti-TNF)
0
0.65
Cytokines
0
0.75
Arthritis
0
0.4
Biologic Therapy
0
0.16
Interleukin
0
0.75
Specialty
Lead
score
Rheumatology
1
1
Dermatology
0
1
Family Medicine/Primary Care
0
1
Orthopaedics
0
0.48
Edit Tags